吉祥坊登录

São Paulo, Brazil—Minos™ Abdominal Aortic Stent-Graft and Delivery System (“Minos™ Stent Graft System”), a product developed by Shanghai MicroPort Endovascular MedTech(Group) Co., Ltd. (“Endovastec™”), was used in Brazil for the first time in a recently completed  case. This marks the tenth overseas market that the Minos™ Stent Graft System has entered, after Greece, Poland, Spain, Germany, Italy, Switzerland, Argentina, Croatia and Hungary.

The procedure was performed by a surgical team led by Dr. Victor Maia and Dr. Guilherme Meirelles of the Samaritano Paulista Hospital. The patient was admitted to the hospital because of a sudden onset of intense pain. Preoperative angiography showed a challenging abdominal aortic aneurysm over 5 cm in diameter involving the superior mesenteric artery and  the access t artery is very tortuous. After discussion, the surgical team selected the Minos™ Stent Graft System for placement across the superior mesenteric artery and used the Chimney technique to reconstruct the superior mesenteric artery and the left and right renal arteries. Postoperative angiography showed an effectively isolated aneurysm, and the stent graft was well conformed to the patient’s anatomy, the blood flow in the branch stent was patent, which indicated a successful operation. The doctor commented that, “It is the outstanding performance of Minos™ that made the procedure a success. The ultra-low profile delivery sheath of Minos™ is able to smoothly pass through the patient’s tortuous iliac artery. In addition, the sense of control of the delivery system is excellent and the procedure is very smooth. ”

The Minos™ Stent Graft System features a three-piece design that enables a flexible assembly to accommodate different size requirements. Its main body was constructed from a laser-cut M-stent with integrated barbs and covered with seamless woven graft, and its iliac limbs are woven by a single wire in a spiraling pattern. The advanced core technologies are able to meet the treatment needs of a wider range of abdominal aortic aneurysms with complex anatomy, which reduces the rate of complications such as device migration, endoleaks or occlusion, and thus lower the risk of long-term reintervention.

Zhenghua Miao, President of Endovastec™, said, “Since Minos™ entered overseas markets, the Minos™ Stent Graft System has shown excellent performance in clinical practice in a number of countries in Europe and South America. It has been well recognized by experts for providing a better solution for overseas patients with complex abdominal aortic anatomical patterns. With the continuous steps in overseas market, Endovastec™ will further enhance in-depth cooperation with overseas clinical experts, striving to promote more high-quality and innovative solutions for the treatment of aortic and peripheral vascular diseases in overseas markets, so as to benefit more patients worldwide. ”